• English
  • Korean
  • Chinese
市場調査レポート - 238090

日本の血液凝固検査市場

Japanese Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers

発行 Venture Planning Group
出版日 ページ情報 英文
価格
日本の血液凝固検査市場 Japanese Coagulation Market Outlook: Innovations, Trends and Opportunities for Suppliers
出版日: 2013年05月16日 ページ情報: 英文
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、日本の血液凝固検査関連市場の今後の技術・市場見通しについて分析し、研究開発の最新動向と将来展望、今後10年間の市場規模の予測、市場のリスク、主な製品開発機会、主要企業のプロフィルなどを調査して、その結果を概略以下の構成でお届けします。

世界市場と技術概要

  • 主な血液凝固検査(ルーチン検査・特別検査)
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出血時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定(全12種類)
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポたんぱく質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC&S
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 各種装置のレビュー(全44種)
  • 主要な体外診断技術と潜在的な用途
    • 発色基質
    • モノクローナル抗体とポリクローナル抗体
    • 免疫学的検定
    • マイクロコンピュータ
    • オートメーション
    • ロボット工学
    • DNAプローブ
    • 人工知能
    • ドライケミストリー
    • バイオセンサー
  • 世界市場の概況
    • 事業環境
    • 市場構造
    • 市場規模・成長
    • POC(Point of Care)検査市場

日本市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主なサプライヤー

主な製品開発機会

分散検査製品の設計基準

代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業評価

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

This report presents a comprehensive analysis of the Japanese coagulation market, including:

  • Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 coagulation procedures performed in Japanese hospitals and commercial laboratories, including typical coagulation daily work loads.
  • Placement estimates for major automated and semiautomated systems.
  • Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of coagulation technologies and their potential market applications.
  • Major opportunities for coagulation instruments and consumables.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 402 pages and 18 tables

Table of Contents

Worldwide Market and Technology Overview

  • A. Major Routine and Special Coagulation Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
    • Introduction
    • Benk Hemolab
    • Benk TRT Thrombotimer
    • Bio/Data MCA 310
    • Bio/Data MCA 210
    • Bio/Data PAP-4C D/4D/4C
    • Cardiovascular Diagnostics COAG
    • Diagnostica Stago STA Compact
    • Diagnostica Stago STA-R
    • Diagnostica Stago Star 4/8
    • Helena Laboratories Cascade 480
    • Helena Laboratories Cascade M
    • Helena Laboratories PACKS-4
    • Helena THOR
    • Instrumentation Laboratory ACL 100 and 1000 series
    • Instrumentation Laboratory ACL6000
    • Instrumentation Laboratory ACL7000
    • Instrumentation Laboratory ACL9000
    • Instrumentation Laboratory Electra 1000C
    • Instrumentation Laboratory Electra 1400C
    • Instrumentation Laboratory Electra 1600/C
    • Instrumentation Laboratory Electra 1800C
    • Instrumentation Laboratory Futura
    • ITC Hemochron 8000
    • Roche Diagnostics CoaguChek
    • Siemens BCS
    • Siemens BCT
    • Siemens BF II/Fibrintimer Series
    • Sysmex CA-50
    • Sysmex CA-500
    • Sysmex CA-1500
    • Sysmex CA-5000/CA-1000
    • Sysmex CA-6000
    • Sysmex CA-7000
    • Teco Coatron II/Jr./AccuStasis 5000
    • Trinity Biotech Amax CS190
    • Trinity Biotech Amax CS400
    • Trinity Biotech Coag-A-Mate Max
    • Trinity Biotech KC 40, 4A, 1A Series
    • Trinity Biotech MDA 180
    • Trinity Biotech Coag-A-Mate MTX
    • Trinity Biotech Coag-A-Mate RA4
    • Trinity Biotech Coag-A-Mate XC/Plus
    • Trinity Biotech Coag-A-Mate XM
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Chromogenic Substrates
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Applications
      • b. Technological Principle
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Dot Immunobinding Assays
        • Capillary Immunoassays
        • Enzyme Amplification
        • Electrochemical Immunoassay
      • d. Fluorescent Immunoassays
        • Fluorescence Polarization
        • Time-Resolved Pulse Fluorescence
        • Fluorescence Lifetime
      • e. Latex Agglutination
      • f. Immunoprecipitation
    • 4. Microcomputers
    • 5. Automation
    • 6. Robotics
    • 7. DNA Probes
      • a. Overview
      • b. Amplification Methods
        • PCR
        • Ligase Chain Reaction
        • Branched DNA
        • Q-Beta Replicase
        • NASBA
        • SDA
        • 3 SR
        • HPA
        • Two-Tiered System
        • LAT
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors
  • D. Worldwide Market Overview
    • 1. Business Environment
    • 2. Market Structure
    • 3. Market Size and Growth
    • 4. POC Testing Market

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Executive Summary Table: Japan, Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
  • Japan, Laboratories Performing Coagulation Tests By Market Segment, 2010
  • Japan, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
  • Japan, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
  • Japan, Hospital Laboratories Average Daily Test Volume, 2010
  • Japan, Commercial/Private Laboratories Average Daily Test Volume, 2010
  • Japan, Total Coagulation Test Volume By Market Segment, 2010-2020
  • Japan, All Market Segments Coagulation Test Volume, 2010-2020
  • Japan, Hospital Laboratories Coagulation Test Volume, 2010-2020
  • Japan, Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
  • Japan, Coagulation Reagent Market By Market Segment, 2010-2020
  • Japan, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
  • Japan, Coagulation Instrument Market By Market Segment, 2010-2020
  • Japan, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • Japan, Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • Japan, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • Japan, Total Coagulation Diagnostics Market By Product Category, 2010-2020
  • Japan, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010
Back to Top